Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GUS: Gadavist Drug Utilization Study

NCT05350189 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05350189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05350189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GUS: Gadavist Drug Utilization Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 3, 2022
Completion date
April 27, 2023
Enrollment
1,602 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

contrast enhancement in magnetic resonance imaging